- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer ; volume:14 ; number:1 ; day:31 ; month:7 ; year:2024 ; pages:1-9 ; date:12.2024
Scientific reports ; 14, Heft 1 (31.7.2024), 1-9, 12.2024
- Urheber
-
Choi, Eugene
Shin, Jinho
Ryu, Min-Hee
Kim, Hyung-Don
Park, Young Soo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-68411-w
- URN
-
urn:nbn:de:101:1-2410250848225.533760406762
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Choi, Eugene
- Shin, Jinho
- Ryu, Min-Hee
- Kim, Hyung-Don
- Park, Young Soo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Temporal heterogeneity of HER2 expression in metastatic gastric cancer: a case report
Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
Personalisierte Therapieoptionen beim Ösophaguskarzinom - Relevanz der Expression von Mesothelin und Claudin 18.2
MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2
Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Temporal heterogeneity of HER2 expression in metastatic gastric cancer: a case report
Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
Personalisierte Therapieoptionen beim Ösophaguskarzinom - Relevanz der Expression von Mesothelin und Claudin 18.2
MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2
Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Temporal heterogeneity of HER2 expression in metastatic gastric cancer: a case report
Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
Personalisierte Therapieoptionen beim Ösophaguskarzinom - Relevanz der Expression von Mesothelin und Claudin 18.2
MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2